Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-24 @ 7:12 PM
NCT ID:
NCT04354103
Eligibility Criteria:
Inclusion Criteria:
* High impulsive patients, aged 10-35 years old, diagnosed for Tourette's syndrome as defined by the DSM-IV, never treated by Atomoxetine
* The use of effective contraception or abstinence for subjects of reproductive age
* Written informed consent
Exclusion Criteria:
* Patients with mental retardation, psychotic disorders as schizophrenia, autism spectrum disorders, chronic tics which do not respond to Tourette's syndrome criteria.
* Actual severe depression
* Allergy to one of the constituents
* Severe cardiovascular or cerebrovascular diseases, Pheochromocytoma, uncontrolled hyperthyroidism, closed angle glaucoma
* IMAO treatment discontinued less than 2 months or contra-indicated associated treatment
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
35 Years
Study:
NCT04354103
Study Brief:
Protocol Section:
NCT04354103